Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
26S proteosome (Homo sapiens (Human)) | BDBM446619![]() (US10669289, Compound 26) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
MERCK PATENT GMBH US Patent | Assay Description Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s... | US Patent US10669289 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
26S proteosome (Homo sapiens (Human)) | BDBM446605![]() (US10669289, Compound 12) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
MERCK PATENT GMBH US Patent | Assay Description Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s... | US Patent US10669289 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
26S proteosome (Homo sapiens (Human)) | BDBM446626![]() (US10669289, Compound 33) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
MERCK PATENT GMBH US Patent | Assay Description Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s... | US Patent US10669289 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
26S proteosome (Homo sapiens (Human)) | BDBM446635![]() (US10669289, Compound 42) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
MERCK PATENT GMBH US Patent | Assay Description Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s... | US Patent US10669289 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
26S proteosome (Homo sapiens (Human)) | BDBM446656![]() (US10669289, Compound 63) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
MERCK PATENT GMBH US Patent | Assay Description Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s... | US Patent US10669289 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
26S proteosome (Homo sapiens (Human)) | BDBM446658![]() (US10669289, Compound 65) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
MERCK PATENT GMBH US Patent | Assay Description Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s... | US Patent US10669289 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
26S proteosome (Homo sapiens (Human)) | BDBM446663![]() (US10669289, Compound 70) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
MERCK PATENT GMBH US Patent | Assay Description Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s... | US Patent US10669289 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
26S proteosome (Homo sapiens (Human)) | BDBM446670![]() (US10669289, Compound 77) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
MERCK PATENT GMBH US Patent | Assay Description Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s... | US Patent US10669289 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
26S proteosome (Homo sapiens (Human)) | BDBM446671![]() (US10669289, Compound 78) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
MERCK PATENT GMBH US Patent | Assay Description Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s... | US Patent US10669289 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
26S proteosome (Homo sapiens (Human)) | BDBM446680![]() (US10669289, Compound 87) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
MERCK PATENT GMBH US Patent | Assay Description Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s... | US Patent US10669289 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
26S proteosome (Homo sapiens (Human)) | BDBM446685![]() (US10669289, Compound 92) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
MERCK PATENT GMBH US Patent | Assay Description Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s... | US Patent US10669289 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
26S proteosome (Homo sapiens (Human)) | BDBM446602![]() (US10669289, Compound 9) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
MERCK PATENT GMBH US Patent | Assay Description Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s... | US Patent US10669289 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
26S proteosome (Homo sapiens (Human)) | BDBM446604![]() (US10669289, Compound 11) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
MERCK PATENT GMBH US Patent | Assay Description Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s... | US Patent US10669289 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
26S proteosome (Homo sapiens (Human)) | BDBM446608![]() (US10669289, Compound 15) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
MERCK PATENT GMBH US Patent | Assay Description Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s... | US Patent US10669289 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
26S proteosome (Homo sapiens (Human)) | BDBM446613![]() (US10669289, Compound 20) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
MERCK PATENT GMBH US Patent | Assay Description Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s... | US Patent US10669289 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
26S proteosome (Homo sapiens (Human)) | BDBM446629![]() (US10669289, Compound 36) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
MERCK PATENT GMBH US Patent | Assay Description Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s... | US Patent US10669289 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
26S proteosome (Homo sapiens (Human)) | BDBM446637![]() (US10669289, Compound 44) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
MERCK PATENT GMBH US Patent | Assay Description Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s... | US Patent US10669289 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
26S proteosome (Homo sapiens (Human)) | BDBM446675![]() (US10669289, Compound 82) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
MERCK PATENT GMBH US Patent | Assay Description Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s... | US Patent US10669289 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
26S proteosome (Homo sapiens (Human)) | BDBM446678![]() (US10669289, Compound 85) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
MERCK PATENT GMBH US Patent | Assay Description Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s... | US Patent US10669289 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
26S proteosome (Homo sapiens (Human)) | BDBM446683![]() (US10669289, Compound 90) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
MERCK PATENT GMBH US Patent | Assay Description Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s... | US Patent US10669289 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
26S proteosome (Homo sapiens (Human)) | BDBM446697![]() (US10669289, Compound 104) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
MERCK PATENT GMBH US Patent | Assay Description Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s... | US Patent US10669289 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
26S proteosome (Homo sapiens (Human)) | BDBM446600![]() (US10669289, Compound 7) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
MERCK PATENT GMBH US Patent | Assay Description Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s... | US Patent US10669289 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
26S proteosome (Homo sapiens (Human)) | BDBM446636![]() (US10669289, Compound 43) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
MERCK PATENT GMBH US Patent | Assay Description Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s... | US Patent US10669289 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
26S proteosome (Homo sapiens (Human)) | BDBM446653![]() (US10669289, Compound 60) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
MERCK PATENT GMBH US Patent | Assay Description Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s... | US Patent US10669289 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
26S proteosome (Homo sapiens (Human)) | BDBM446664![]() (US10669289, Compound 71) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
MERCK PATENT GMBH US Patent | Assay Description Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s... | US Patent US10669289 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
26S proteosome (Homo sapiens (Human)) | BDBM446691![]() (US10669289, Compound 98) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
MERCK PATENT GMBH US Patent | Assay Description Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s... | US Patent US10669289 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
26S proteosome (Homo sapiens (Human)) | BDBM446694![]() (US10669289, Compound 101) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
MERCK PATENT GMBH US Patent | Assay Description Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s... | US Patent US10669289 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
26S proteosome (Homo sapiens (Human)) | BDBM446609![]() (US10669289, Compound 16) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
MERCK PATENT GMBH US Patent | Assay Description Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s... | US Patent US10669289 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
26S proteosome (Homo sapiens (Human)) | BDBM446616![]() (US10669289, Compound 23) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
MERCK PATENT GMBH US Patent | Assay Description Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s... | US Patent US10669289 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
26S proteosome (Homo sapiens (Human)) | BDBM446622![]() (US10669289, Compound 29) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
MERCK PATENT GMBH US Patent | Assay Description Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s... | US Patent US10669289 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
26S proteosome (Homo sapiens (Human)) | BDBM446643![]() (US10669289, Compound 50) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
MERCK PATENT GMBH US Patent | Assay Description Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s... | US Patent US10669289 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
26S proteosome (Homo sapiens (Human)) | BDBM446659![]() (US10669289, Compound 66) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
MERCK PATENT GMBH US Patent | Assay Description Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s... | US Patent US10669289 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
26S proteosome (Homo sapiens (Human)) | BDBM446687![]() (US10669289, Compound 94) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
MERCK PATENT GMBH US Patent | Assay Description Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s... | US Patent US10669289 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
26S proteosome (Homo sapiens (Human)) | BDBM446692![]() (US10669289, Compound 99) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
MERCK PATENT GMBH US Patent | Assay Description Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s... | US Patent US10669289 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
26S proteosome (Homo sapiens (Human)) | BDBM446594![]() (US10669289, Compound 1) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
MERCK PATENT GMBH US Patent | Assay Description Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s... | US Patent US10669289 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
26S proteosome (Homo sapiens (Human)) | BDBM446597![]() (US10669289, Compound 4) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
MERCK PATENT GMBH US Patent | Assay Description Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s... | US Patent US10669289 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
26S proteosome (Homo sapiens (Human)) | BDBM446649![]() (US10669289, Compound 56) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
MERCK PATENT GMBH US Patent | Assay Description Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s... | US Patent US10669289 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
26S proteosome (Homo sapiens (Human)) | BDBM446674![]() (US10669289, Compound 81) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
MERCK PATENT GMBH US Patent | Assay Description Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s... | US Patent US10669289 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
26S proteosome (Homo sapiens (Human)) | BDBM446681![]() (US10669289, Compound 88) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
MERCK PATENT GMBH US Patent | Assay Description Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s... | US Patent US10669289 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
26S proteosome (Homo sapiens (Human)) | BDBM446689![]() (US10669289, Compound 96) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
MERCK PATENT GMBH US Patent | Assay Description Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s... | US Patent US10669289 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
26S proteosome (Homo sapiens (Human)) | BDBM446695![]() (US10669289, Compound 102) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
MERCK PATENT GMBH US Patent | Assay Description Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s... | US Patent US10669289 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
26S proteosome (Homo sapiens (Human)) | BDBM446696![]() (US10669289, Compound 103) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
MERCK PATENT GMBH US Patent | Assay Description Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s... | US Patent US10669289 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
26S proteosome (Homo sapiens (Human)) | BDBM446596![]() (US10669289, Compound 10 | US10669289, Compound 3) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
MERCK PATENT GMBH US Patent | Assay Description Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s... | US Patent US10669289 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
26S proteosome (Homo sapiens (Human)) | BDBM446606![]() (US10669289, Compound 13) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
MERCK PATENT GMBH US Patent | Assay Description Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s... | US Patent US10669289 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
26S proteosome (Homo sapiens (Human)) | BDBM446634![]() (US10669289, Compound 41) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
MERCK PATENT GMBH US Patent | Assay Description Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s... | US Patent US10669289 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
26S proteosome (Homo sapiens (Human)) | BDBM446648![]() (US10669289, Compound 55) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
MERCK PATENT GMBH US Patent | Assay Description Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s... | US Patent US10669289 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
26S proteosome (Homo sapiens (Human)) | BDBM446654![]() (US10669289, Compound 61) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
MERCK PATENT GMBH US Patent | Assay Description Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s... | US Patent US10669289 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
26S proteosome (Homo sapiens (Human)) | BDBM446667![]() (US10669289, Compound 74) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
MERCK PATENT GMBH US Patent | Assay Description Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s... | US Patent US10669289 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
26S proteosome (Homo sapiens (Human)) | BDBM446679![]() (US10669289, Compound 86) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
MERCK PATENT GMBH US Patent | Assay Description Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s... | US Patent US10669289 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
26S proteosome (Homo sapiens (Human)) | BDBM446688![]() (US10669289, Compound 95 | [(1R)-1-[[2-(3,5-dichlor...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
MERCK PATENT GMBH US Patent | Assay Description Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s... | US Patent US10669289 (2020) | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 209 total ) | Next | Last >> |